Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis

Gut

Volumn 46, Issue 5, 2000, Pages 711-714

  Chapoutot, C ^a   Joomaye, Z ^a   Perney, P ^a   Laurent, C ^a   Fabbro Peray, P ^a   Blanc, F ^a   Esslimani, M ^a   Ramos, J ^a   Larrey, D ^a   Domergue, J ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Hepatocellular carcinoma; Iron; Liver; Viral C cirrhosis

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER SINUSOID; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS;

EID: 0034027392     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.711     Document Type: Article

References (32)

1. 1 Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997;3 (suppl 1):34-8.
2. 2 Di Bisceglie AM, Simpson LH, Lotze MT, et al. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994;19:222-6.
3. 3 Kew MC, Yu MC, Kedda M, et al. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African Blacks. Gastroenterology 1997;112:184-7.
4. 4 Ganne-Carrié N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatohgy 1996;23:1112-18.
5. 5 Brunetto MR, Oliveri F, Koehler M, et al. Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 1998;351: 1535-9.
6. 6 Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Mesurement of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
7. 7 Isomura T, Yano M, Hayashi H, et al. Excess iron in the liver of patients with chronic hepatitis C. J Clin Electron Microsc 1992;25:231-7.
8. 8 Piperno A, D'Alba R, Fargion S, et al. Liver iron concentration in viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995;7:1203-8.
9. 9 Smith BC, Grove J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998;27:1695-9.
10. 10 Deugnier Y, Turlin B, Loréal O. Iron and neoplasia. J Hepatol 1998;28:21-5.
11. 11 Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 1995;22:446-50.
12. 12 Anthony PP, Ishak K, Nayak NC, et al. The morphology of cirrhosis. J Clin Pathol 1978;3:395-414.
13. 13 Deugnier Y, Loréal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-9.
14. 14 Turlin B, Robert I, Maugendre S, et al. Quantification histologique des hépatosidéroses hémochromatosiques et non hémochromatosiques. Ann Pathol 1997;5:329-32.
15. 15 Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973;26:217-23.
16. 16 Fong T, Shindo M, Feinstone SM, et al. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 1991;88:1058-60.
17. 17 Shafritz DA, Shouval D, Sherman HI, et al. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 1981;305:1067-73.
18. 18 Tanaka K, Hirohata T, Ikematsu H, et al. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst 1996;88:742-6.
19. 19 Bruno S, Silini S, Crosignani A, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997;25:754-8.
20. 20 Benvegnu L, Pontisso P, Cavalletto D, et al. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997;25:211-15.
21. 21 Naoumov NV, Chokshi S, Metivier E, et al. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J Hepatol 1997;27:331-6.
22. 22 Kasahara A, Hayashi N, Mochizuki K, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998;27:1394-402.
23. 23 Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-8.
24. 24 Nishiguchi S, Kuroki T, Nakatani S, et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
25. 25 Sampietro M, Boldorini R, Corbetta N, et al. Liver iron distribution, histological activity and mutations in the hemochromatosis gene (HFE) in chronic hepatitis C [abstract]. J Hepatol 1998;28 (suppl):98A.
26. 26 Hézode C, Cazeneuve C, Coué O, et al. Liver iron overload in patients with chronic active hepatitis C. Prevalence, role of the hemochromatosis gene and relation with hepatic histological lesion [abstract]. J Hepatol 1998;28 (suppl):110A.
27. 27 Curry GW, Thorburn D, Spooner RJ, et al. Heterozygosity for the C282Y mutation of the HFE gene is not associated with altered iron status or increased fibrosis in chronic hepatitis C (HCV) [abstract]. Hepatology 1998;28 (suppl): 451A.
28. 28 Pirisi M, Toniutto P, Scott C, et al. HFE missense mutations, histological activity index and hemosiderosis in chronic hepatitis C [abstract]. Hepatology 1998;28 (suppl): 805A.
29. 29 Kaji K, Nakanuma Y, Sasaki M, et al. Hemosiderin deposition in portal endothelial cells : a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum Pathol 1995;26:1080-5.
30. 30 Stal P, Hultcrantz R, Moller L, et al. The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology 1995;21:221-8.
31. 31 Carthew P, Nolan MB, Smith AG, et al. Iron promotes DEN initiated GST-P foci in rat liver. Carcinogenesis 1997;18: 599-603.
32. 32 Meneghini H. Iron homeostasis, oxidative stress, and DNA damage. Free Radiac Biol Med 1997;23:783-92.